With a View to Export
Generium (Volginsky town setting, Vladimir region) opens an immunobiological product production facility.
The site will manufacture albumins, immunoglobulins, blood factors. As the manufacture reaches the design capacity admittedly this summer, it will manufacture 11 products for treatment of cancers, strokes and infarctions, as well as for large scale tuberculosis screening.
The new facility will cover the local requirements in that group of products but will also be responsible for export. “We do hope, says Alexander Shuster, President of International Biotechnological Center Generium, to launch clinical trials of a drug for TB detection Diascintest in the united Europe and USA area. A meeting of European Medicines Agency which will approve study design will be held so that the drug enters the approved WHO list”.